erythromycin has been researched along with Disease Models, Animal in 142 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (16.90) | 18.7374 |
| 1990's | 38 (26.76) | 18.2507 |
| 2000's | 43 (30.28) | 29.6817 |
| 2010's | 25 (17.61) | 24.3611 |
| 2020's | 12 (8.45) | 2.80 |
| Authors | Studies |
|---|---|
| Beebe, X; Bui, MH; Djuric, SW; Ma, Z; Mitten, MJ; Nilius, AM; Yang, F | 1 |
| Manfredini, S; Mercurio, TP; Mereu, A; Moriggi, E; Napoletano, M; Pellacini, F; Regazzoni, C | 1 |
| Kasahara, K; Kita, E; Mikasa, K; Mizuno, F; Nishi, K; Yasuda, Y | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
| Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO | 1 |
| Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN | 1 |
| Guo, HF; Jin, J; Li, ZR; Liu, ZY; Xie, ZS; Xue, ST; Yi, H; Zhang, L | 1 |
| Domon, H; Hirayama, S; Hiyoshi, T; Isono, T; Maekawa, T; Sasagawa, K; Tamura, H; Terao, Y; Yanagihara, K | 1 |
| Barzegar, KEF; Barzegar, PEF; Farjanikish, G; Hayati, FZ; Ranjbar, R; Tahmasebi, E; Tebyaniyan, H; Yazdanian, M | 1 |
| Cai, C; Chu, X; Weng, B; Yin, X; Zhang, X | 1 |
| Mass, E; Splichalova, I | 1 |
| Kato, G; Kimura, S; Kurata, K; Noguchi, Y; Ōmura, S; Sadamatsu, H; Sueoka-Aragane, N; Sunazuka, T; Takahashi, K; Tashiro, H | 1 |
| Balkrishna, A; Bhattacharya, K; Rustagi, Y; Varshney, A | 1 |
| Kato, G; Kimura, S; Kurata, K; Kurihara, Y; Noguchi, Y; Ōmura, S; Sadamatsu, H; Sueoka-Aragane, N; Sunazuka, T; Takahashi, K; Tashiro, H; Uchida, M | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Könemann, H; Rath, B; Reinke, F; Wegner, FK; Willy, K; Wolfes, J | 1 |
| Guo, P; Qian, C; Sun, S; Wang, N; Wang, Y; Xu, H; Yang, D; Zhong, Y | 1 |
| Ahmad, Z; Akhtar, A; Arshad, MS; Ayaz, MM; Chang, MW; Kucuk, I; Maniruzzaman, M; Zafar, S; Zahra, AT; Zaman, H | 1 |
| Chen, Z; Gan, L; Huang, Z; Li, W; Liu, G; Qin, C; Wei, P; Zeng, T | 1 |
| Gao, Y; Liu, W; Lu, Y; Pan, C; Yin, P; Yu, X; Zhou, Z | 1 |
| Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Krawczyk, J | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M | 1 |
| Aktan, B; Ersoy, B; Kilic, K; Sakat, MS; Sipal, S | 1 |
| Gu, Y; Huang, LM; Li, G | 1 |
| Cuff, LE; Dewan, KK; Gestal, MC; Hamidou Soumana, I; Harvill, ET; Levin, BR; Rivera, I; Rodriguez, C; Ryman, VE; Skarlupka, AL; Taylor-Mulneix, DL; Wagner, S | 1 |
| Cai, Y; Cao, L; Cao, Y; Chen, J; Lei, Y; Yang, X; Zhang, K | 1 |
| Baeg, MK; Choi, MG; Lim, CH; Park, H; Park, JM | 1 |
| Guo, ZZ; Li, GY; Lu, WC; Qiu, B; Xie, H; Yang, RM | 1 |
| Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K | 1 |
| Inaba, T; Katayama, Y; Katsura, K; Nito, C; Ueda, M | 1 |
| Berndt, A; Liebler-Tenorio, E; Lohr, M; Ostermann, C; Prohl, A; Reinhold, P; Rothe, M; Sachse, K; Schroedl, W; Schubert, E | 1 |
| Ampatzidou, FC; Ananiadou, OG; Charchanti, AV; Drossos, GE; Johnson, EO; Koutsogiannidis, CP; Mytilinaios, DG; Nikolopoulou, EN; Savvas, IP; Troupis, TG | 1 |
| Akagawa, KS; Hanaki, H; Hirose, T; Matsui, H; Nakano, H; Ōmura, S; Shima, H; Sueki, A; Sugawara, A; Sunazuka, T | 1 |
| Cheng, C; Du, L; He, Y; Lu, Q; Ran, T; Yu, J | 1 |
| Inaba, T; Katayama, Y; Nito, C; Ueda, M | 1 |
| Chatuphonprasert, W; Jarukamjorn, K; Tatiya-Aphiradee, N | 1 |
| Abel, T; Bizily, SF; Esposito, MF; Favilla, C; Kanes, SJ; Kelly, MP; Stein, JM; Vecsey, CG; Wand, G; Yang, X | 1 |
| Hawkins, M; Markel, DC; Ren, W; Shi, T; Zhang, R | 1 |
| Gong, M; Huang, XH; Jiang, WL; Li, T; Liu, J; Yang, ZQ | 1 |
| Boisvert, C; Dani, M; Leblond, FA; Lefrançois, S; Michaud, J; Naud, J; Pichette, V | 1 |
| Garba, SH; Sambo, N; Timothy, H | 1 |
| Goto, H; Higaki, M; Ishii, H; Kamiya, S; Mikura, S; Wada, H; Yasutake, T | 1 |
| Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I | 1 |
| Kuang, W; Liu, L; Tan, X; Wan, L; Zhou, Y | 1 |
| Kong, L; Leeming, AH; Weisman, LE | 1 |
| Aziz, Q; Broad, J; Bulmer, DC; Dukes, GE; Javid, FA; Sanger, GJ | 1 |
| Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W | 1 |
| Aoyama, A; Azuma, A; Kudoh, S; Li, Y; Matsuda, K; Takahashi, S; Usuki, J | 1 |
| Enomoto, F | 1 |
| Enomoto, F; Fujimori, M; Ichikawa, G; Kataoka, T; Kin, R; Nagaoka, I; Yamazaki, Y; Yokoi, H | 1 |
| Aguilar, L; Carcas, A; Cenjor, C; Garcia-Olmos, M; Gimenez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
| Banevicius, MA; Capitano, B; Maglio, D; Nicolau, DP; Nightingale, CH | 1 |
| Asano, K; Kadokawa, T; Kadota, J; Kaida, H; Kawano, S; Koji, T; Kuroki, M; Mukae, H; Nagata, T; Yanagihara, K | 1 |
| Bai, J; Feng, ZB; Liang, GR; Shi, HZ; Wu, C; Zhong, XN | 1 |
| Aguilar, L; Cenjor, C; García-Olmos, M; Giménez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
| Arafah, M; El-Medany, A; Mahgoub, A; Moursi, M; Mustafa, A | 1 |
| Muranaka, H; Okamoto, S; Okamoto, T; Sato, K; Suga, M; Takahashi, T | 1 |
| Cenjor, C; del Prado, G; García-Cía, JI; Granizo, JJ; Huelves, L; Martínez-Marín, C; Ponte, C; Soriano, F | 1 |
| Chen, BD; Mayton, L; Peng, X; Ren, J; Ren, W; Wooley, PH; Wu, B; Yu, D | 1 |
| Miwa, M; Sugatani, J; Takagi, S; Yoshimasa, T; Yoshinari, K | 1 |
| Bakardjiev, AI; Portnoy, DA; Theriot, JA | 1 |
| Azoulay-Dupuis, E; Barau, C; Bédos, JP; Fantin, B; Mohler, J | 1 |
| Cenjor, C; del Prado, G; Fernández-Roblas, R; Gracia, M; Huelves, L; Martínez-Marín, C; Ponte, C; Rodríguez-Cerrato, V; Soriano, F | 1 |
| Guo, SM; Zhong, XN | 1 |
| Brambrink, AM; Gatting, M; Kempski, O; Koerner, IP; Noppens, R | 1 |
| Cynshi, O; Itoh, Z; Kamei, K; Koga, H; Muramatsu, H; Omura, S; Ozaki, K; Sudo, H; Takanashi, H; Yogo, K | 1 |
| Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H | 1 |
| Akima, M; Itoh, Z; Kamei, K; Koga, H; Omura, S; Onoma, M; Ozaki, K; Takanashi, H; Yogo, K | 1 |
| Hayashi, S; Itoh, Z; Kamei, K; Kawabe, Y; Matsuo, S; Monnai, M; Muramatsu, H; Omura, S; Onoma, M; Ozaki, K; Shiga, T; Suzuki, M; Takanashi, H; Yogo, K | 1 |
| Ballaron, SJ; De Young, LM; Puhvel, SM; Spires, DA; Young, JM | 1 |
| Iversen, P; Jensen, KM; Madsen, PO | 1 |
| Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R | 1 |
| Beck, DE; Karulf, RE | 1 |
| Ellis, W; Fayer, R | 1 |
| Bergeron, JM; Girard, D; Milisen, WB; Retsema, JA | 1 |
| Baskerville, A; Fitzgeorge, RB; Lever, S | 1 |
| Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
| Bergeron, JM; Girard, AE; Girard, D; Milisen, WB; Retsema, JA | 1 |
| Smith, GR; Thornton, EA | 1 |
| Lagrange, PH | 1 |
| Pocidalo, JJ; Veber, B | 1 |
| Aho, P; Höök-Nikanne, J; Kärkkäinen, P; Kosunen, TU; Salaspuro, M | 1 |
| Allen, RH; Buccellato, FR; Lindenbaum, J; Lorenzini, EC; Morabito, A; Scalabrino, G; Tredici, G | 1 |
| Chiba, T; Kobayashi, T; Marcus, DC; Ohyama, K; Rong, Y; Takasaka, T | 1 |
| Bayer, A; Bolger, AF; Dajani, AS; Ferrieri, P; Gage, TW; Gewitz, MH; Hutto, C; Levison, ME; Newburger, JW; Nouri, S; Pallasch, TJ; Peter, G; Shulman, ST; Taubert, KA; Wilson, W; Zuccaro, G | 1 |
| Chen, B; Hou, XM; Jiang, L; Yu, R; Zhao, W | 1 |
| den Hollander, JG; Espersen, F; Frimodt-Møller, N; Fuursted, K; Knudsen, JD; Mouton, JW; Verbrugh, HA | 1 |
| Ando, M; Miyashima, S; Sato, K; Suga, M | 1 |
| Edelstein, PH | 1 |
| Scott, RB; Shaffer, EA; Tan, DT; Xu, QW | 1 |
| Barg, N | 1 |
| Argyropoulou, A; Chalevelakis, G; Danias, PG; Mylonakis, EE; Paniara, O; Raptis, SA; Saroglou, G | 1 |
| Hirayama, F; Iizumi, Y; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
| Muller-Serieys, C | 1 |
| Ando, M; Ito, K; Miyajima, M; Nakagawa, K; Suga, M | 1 |
| Ando, M; Ichiyasu, H; Matsukawa, A; Okamoto, R; Okawara, S; Sato, K; Suga, M; Takahashi, T; Yoshinaga, H | 1 |
| Araujo, FG; Craft, JC; Khan, AA; Remington, JS | 1 |
| Murray, BE; Singh, KV; Zscheck, KK | 1 |
| Charles, PE; Chavanet, P; Desbiolles, N; Lequeu, C; Martin, L; Mateo-Ponce, V; Piroth, L; Portier, H | 1 |
| Akbulut, A; Demirdag, K; Felek, S; Kalkan, A | 1 |
| Gerding, DN; Johnson, S; Merrigan, MM; Sambol, SP; Tang, JK | 1 |
| Ando, M; Ichiyasu, H; Matsukawa, A; Ohkawara, S; Okamoto, T; Sato, K; Suga, M; Takahashi, T; Yoshinaga, M | 1 |
| Ando, M; Ichiyasu, H; Matsukawa, A; Okamoto, T; Okawara, S; Sato, K; Suga, M; Takahashi, T; Yoshinaga, S | 1 |
| Aoshiba, K; Isono, K; Kondo, M; Kori, K; Nagai, A; Tagaya, E; Tamaoki, A | 1 |
| Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A | 1 |
| Edelstein, MA; Edelstein, PH; Higa, F | 1 |
| Liu, J; Peng, D; Zhu, Z | 1 |
| He, B; Li, Y; Wang, H | 1 |
| Bopp, C; Feeley, JC; Fraser, DW; Tsai, TF; Wachsmuth, I | 1 |
| Hamilton-Miller, JM | 1 |
| Hirth, RS; Price, KE; Tsai, YH; Williams, EB | 1 |
| Futrell, JW; Roberts, TL; Sande, MA | 1 |
| Kupferman, A; Leibowitz, HM | 1 |
| Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
| Araujo, FG; Lin, T; Remington, JS | 1 |
| Chen, HY; Maskell, JP; Powell, M | 1 |
| Bali, JP; Cros, G; Serrano, JJ; Soulié, ML | 1 |
| Gritz, DC; Hwang, D; McDonnell, JM; McDonnell, PJ | 1 |
| Hamada, K; Kashiba, S; Kita, E; Konishi, M; Kunimatsu, M; Mikasa, K; Narita, N; Sawaki, M | 1 |
| Ayalew, S; Barron, SJ; Burrows, GE; Clarke, CR | 1 |
| Araujo, FG; Prokocimer, P; Remington, JS | 1 |
| Rehg, JE | 1 |
| Araujo, FG; Remington, JS; Shepard, RM | 1 |
| Pechère, JC | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
| Girard, AE; Girard, D; Retsema, JA | 1 |
| Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS | 1 |
| Cimochowski, CR; English, AR; Faiella, JA; Girard, AE; Girard, D; Gootz, TD; Haskell, SL; Retsema, JA | 1 |
| Chan, KH; Doyle, WJ; Kardatzke, DR; Swarts, JD; Tanpowpong, K | 1 |
| Dalziel, K; Dykes, PJ; Marks, R | 1 |
| Dournon, E; Rajagopalan, P | 1 |
| Duray, PH; Johnson, RC; Kodner, C; Russell, M | 1 |
| Keys, TF | 1 |
| Köhler, B; Mochmann, H; Richter, U | 1 |
| Binder, P; Bornstein, N; Fleurette, J; Forey, F; Nowicki, M; Paucod, JC | 1 |
| Bonardi, G; Coppi, G | 1 |
| Jawetz, E | 1 |
| Hatala, M; Konicková, L; Loew, H; Prát, V | 2 |
| Linevich, IuG; Otman, LS; Zueva, VS | 1 |
| Gatti, MT; Maccari, M | 1 |
| Biró, L; Iván, E | 1 |
7 review(s) available for erythromycin and Disease Models, Animal
| Article | Year |
|---|---|
[Action mechanism of macrolide antibiotics in experimental otitis media].
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Cell Adhesion Molecules; Child; Disease Models, Animal; Erythromycin; Exudates and Transudates; Humans; Neutrophils; Otitis Media with Effusion | 2001 |
Chronic bacterial prostatitis: theoretical and experimental considerations.
Topics: Animals; Antibody Formation; Antibody-Coated Bacteria Test, Urinary; Bacterial Infections; Chronic Disease; Disease Models, Animal; Dogs; Doxycycline; Erythromycin; Hydrogen-Ion Concentration; Immunoglobulin A; Male; Prostatitis; Sulfamethoxazole; Trimethoprim | 1983 |
[Azithromycin, pharmacodynamic evaluation in animal models].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefaclor; Disease Models, Animal; Erythromycin; Legionnaires' Disease; Listeriosis; Lung Diseases; Mice; Mycobacterium avium; Parasitemia; Salmonella Infections, Animal; Tuberculosis | 1995 |
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
The activity of azithromycin in animal models of infection.
Topics: Animals; Azithromycin; Bacterial Infections; Disease Models, Animal; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Phagocytes; Tissue Distribution | 1991 |
Therapeutic considerations in the treatment of Legionella infections.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Guinea Pigs; Humans; Legionellosis; Microbial Sensitivity Tests; Phagocytes; Rifampin | 1987 |
Chemotherapy of chlamydial infections.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Bird Diseases; Birds; Chlamydia; Chlamydia Infections; Chloramphenicol; Conjunctivitis, Inclusion; Cycloserine; Disease Models, Animal; Erythromycin; Glycosides; Humans; Lymphogranuloma Venereum; Nystatin; Penicillins; Polymyxins; Psittacosis; Sulfonamides; Tetracycline; Trachoma; Vancomycin | 1969 |
135 other study(ies) available for erythromycin and Disease Models, Animal
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Bacterial; Haemophilus influenzae; Ketolides; Macrolides; Rats; Respiratory Tract Infections; Staphylococcus; Structure-Activity Relationship | 2004 |
Design, synthesis and in vivo activity of 9-(S)-dihydroerythromycin derivatives as potent anti-inflammatory agents.
Topics: Amino Sugars; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Edema; Erythromycin; Mice | 2006 |
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Disease Models, Animal; Drug Resistance, Bacterial; Lung; Macrolides; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred CBA; Pneumonia, Pneumococcal; Roxithromycin; Streptolysins | 2007 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection | 2018 |
Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nitriles; Skin Diseases; Staphylococcal Infections | 2019 |
Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes; Zebrafish | 2020 |
Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Down-Regulation; Erythromycin; Humans; Lincosamides; Male; Mice; Mice, Inbred BALB C; Pneumonia; Protein Synthesis Inhibitors; Streptococcus pneumoniae; Streptolysins; Transcription, Genetic | 2021 |
The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections | 2023 |
Erythromycin Attenuates Hyperoxia Induced Lung Injury by Enhancing GSH Expression and Inhibiting Expression of Inflammatory Cytokines.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Chlorides; Cytokines; Disease Models, Animal; Erythromycin; Hyperoxia; Inflammation; Lung; Lung Injury; Rats; Tumor Necrosis Factor-alpha | 2023 |
Fate-Mapping of Yolk Sac-Derived Macrophages.
Topics: Animals; Disease Models, Animal; Embryonic Development; Erythromycin; Macrophages; Mice; Yolk Sac | 2024 |
The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Erythromycin; Female; Lung; Macrophages, Alveolar; Mice, Inbred BALB C; Poly I-C; Pyroglyphidae; Virus Diseases | 2020 |
Application of Zebrafish Model in the Suppression of Drug-Induced Cardiac Hypertrophy by Traditional Indian Medicine Yogendra Ras.
Topics: Animals; Antioxidants; Biomarkers; C-Reactive Protein; Cardiomegaly; Disease Models, Animal; Erythromycin; Heart Defects, Congenital; Isoproterenol; Medicine, Ayurvedic; Oxidative Stress; Phytotherapy; Platelet Aggregation; Rats; Spectrometry, X-Ray Emission; X-Ray Diffraction; Zebrafish | 2020 |
The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma.
Topics: Animals; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Diet, High-Fat; Disease Models, Animal; Erythromycin; Humans; Interleukin-17; Lung; Mice; Mice, Inbred BALB C; Obesity; Pneumonia; Pyroglyphidae; Th2 Cells | 2020 |
Propofol abolishes torsade de pointes in different models of acquired long QT syndrome.
Topics: Action Potentials; Animals; Disease Models, Animal; Electrocardiography; Erythromycin; Heart; Heart Ventricles; Propofol; Rabbits; Risk; Torsades de Pointes | 2020 |
Wound therapy via a photo-responsively antibacterial nano-graphene quantum dots conjugate.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Drug Carriers; Drug Liberation; Erythromycin; Escherichia coli; Female; Graphite; Light; Male; Mice; Nanoparticles; Porosity; Quantum Dots; Silicon Dioxide; Singlet Oxygen; Staphylococcus aureus; Wound Healing | 2020 |
Antibiofilm Effects of Macrolide Loaded Microneedle Patches: Prospects in Healing Infected Wounds.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Erythromycin; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Rats; Salmonella enterica; Skin; Staphylococcus aureus; Transdermal Patch; Wound Healing; Wound Infection | 2021 |
Protective effects of different anti‑inflammatory drugs on tracheal stenosis following injury and potential mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Collagen; Disease Models, Animal; Erythromycin; Granulation Tissue; Histone Deacetylase 2; Hyperplasia; Interleukin-8; Penicillins; Protective Agents; Rabbits; Trachea; Tracheal Stenosis; Transforming Growth Factor beta1; Up-Regulation; Vascular Endothelial Growth Factor A | 2021 |
Combination of Erythromycin and Curcumin Alleviates
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Interleukin-6; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tumor Necrosis Factor-alpha | 2017 |
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Dantrolene; Disease Models, Animal; Electrocardiography; Erythromycin; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Long QT Syndrome; Rabbits; Ryanodine Receptor Calcium Release Channel; Time Factors; Torsades de Pointes; Veratridine | 2018 |
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation | 2018 |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Ear, Middle; Erythromycin; Guinea Pigs; Histamine; Otitis Media with Effusion; Roxithromycin | 2018 |
Inflammation induces Epac-protein kinase C alpha and epsilon signaling in TRPV1-mediated hyperalgesia.
Topics: Acetylcysteine; Action Potentials; Animals; Biotinylation; Capsaicin; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Erythromycin; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Inflammation; Male; Neurons; Patch-Clamp Techniques; Protein Kinase C-alpha; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Signal Transduction; TRPV Cation Channels | 2018 |
Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Toxins; Bordetella bronchiseptica; Bordetella Infections; Cell Survival; Cytokines; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Mice; Mutation; Selection, Genetic; Serial Passage; Virulence | 2018 |
Erythromycin relaxes BALB/c mouse airway smooth muscle.
Topics: Airway Resistance; Animals; Asthma; Bronchodilator Agents; Calcium; Calcium Channels, L-Type; Cyclic AMP; Disease Models, Animal; Erythromycin; Female; Lung; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscle Relaxation; Myocytes, Smooth Muscle; Myography; Trachea | 2019 |
Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test.
Topics: Animals; Body Weight; Breath Tests; Caprylates; Carbon Isotopes; Cross-Over Studies; Disease Models, Animal; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Male; Mice; Mice, Inbred C57BL; Plant Preparations; Random Allocation; Reproducibility of Results; Time Factors | 2013 |
Erythromycin pretreatment induces tolerance against focal cerebral ischemia through up-regulation of nNOS but not down-regulation of HIF-1α in rats.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Disease Models, Animal; Down-Regulation; Erythromycin; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide Synthase Type I; Random Allocation; Rats, Wistar; RNA, Messenger; Severity of Illness Index; Up-Regulation | 2014 |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate | 2014 |
Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
Topics: Animals; Brain Edema; Brain Ischemia; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Erythromycin; Glucose; Hemiplegia; Infarction, Middle Cerebral Artery; Male; Neuroimmunomodulation; Neurons; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cattle; Chlamydophila psittaci; Disease Models, Animal; Enrofloxacin; Erythromycin; Fluoroquinolones; Inflammation; Macrolides; Male; Psittacosis; Rifampin | 2015 |
Decreased DNA Disruption in the Porcine Neocortex with Erythromycin Preconditioning during Prolonged Hypothermic Circulatory Arrest: Evidence for Neuroprotection.
Topics: Animals; Apoptosis; Brain Ischemia; Depression, Chemical; Disease Models, Animal; DNA Fragmentation; Erythromycin; Heart Arrest, Induced; Hypothermia, Induced; Ischemic Preconditioning; Neocortex; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Swine; Time Factors | 2015 |
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Line; Disease Models, Animal; Erythromycin; Guinea Pigs; Lung; Macrolides; Macrophages; Microbial Sensitivity Tests; Monocytes; Pulmonary Disease, Chronic Obstructive; Smoking | 2016 |
Ciprofloxacin plus erythromycin or ambroxol ameliorates endotracheal tube-associated Pseudomonas aeruginosa biofilms in a rat model.
Topics: Ambroxol; Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Female; Male; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiration, Artificial | 2015 |
Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Blood Pressure; Body Temperature; Brain Edema; Brain Infarction; Brain Injuries; Calcium-Binding Proteins; Cerebrovascular Circulation; Deoxyguanosine; Disease Models, Animal; Erythromycin; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Microfilament Proteins; Neuroprotective Agents; Rats; Statistics, Nonparametric; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
In vivo antibacterial activity of Garcinia mangostana pericarp extract against methicillin-resistant Staphylococcus aureus in a mouse superficial skin infection model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Garcinia mangostana; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Plant Extracts; Staphylococcal Skin Infections; Wound Healing; Xanthones | 2016 |
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.
Topics: Acetylcysteine; Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Brain; Cognition Disorders; Conditioning, Psychological; Cyclic AMP; Disease Models, Animal; Erythromycin; Exploratory Behavior; Fear; Female; Gene Expression Regulation, Developmental; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphodiesterase Inhibitors; Psychophysics; Reflex, Startle; Rolipram; Time Factors | 2009 |
Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Erythromycin; Female; Gene Expression Regulation; Interleukin-1; Mice; Mice, Inbred BALB C; Osteolysis; Polyethylenes; RANK Ligand; Sodium Chloride; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2009 |
[Establishment of a rat model of mycoplasma pneumonia and the treatment].
Topics: Animals; Disease Models, Animal; Erythromycin; Female; Male; Microspheres; Pneumonia, Mycoplasma; Random Allocation; Rats; Rats, Wistar | 2009 |
Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
Topics: Animals; Arylamine N-Acetyltransferase; Biotransformation; Creatinine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Disease Models, Animal; Down-Regulation; Erythromycin; Gene Expression Regulation, Enzymologic; Isoenzymes; Kidney Failure, Chronic; Liver; Male; Mice; Mice, Inbred C57BL; Nephrectomy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urea | 2010 |
Effect of the aqueous extract of Psidium guajava on erythromycin-induced liver damage in rats.
Topics: Animals; Biomarkers; Body Weight; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Erythromycin; Liver; Male; Plant Extracts; Plant Leaves; Psidium; Rats | 2009 |
Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke.
Topics: Administration, Oral; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Erythromycin; Lung; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Smoking | 2011 |
Combined effect of disopyramide and erythromycin on ventricular repolarization in dogs with complete atrioventricular block.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Disease Models, Animal; Disopyramide; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Erythromycin; Heart Conduction System; Prognosis; Protein Synthesis Inhibitors; Ventricular Function | 2011 |
Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats.
Topics: Animals; Apoptosis; Disease Models, Animal; Erythromycin; Humans; Interleukin-10; Male; Matrix Metalloproteinase 9; Nicotiana; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Sprague-Dawley; Smoke; Smoking; Tissue Inhibitor of Metalloproteinase-1; Translational Research, Biomedical; Tumor Necrosis Factor-alpha | 2012 |
Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Bacteremia; Disease Models, Animal; Erythromycin; Female; Humans; Mice; Microbial Sensitivity Tests; Pregnancy; Sepsis; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum | 2012 |
Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors.
Topics: Animals; Antiemetics; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Erythromycin; Female; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Motility; Male; Motilin; Muscle Contraction; Nicotine; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Shrews; Stomach; Vagus Nerve; Vomiting | 2013 |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2002 |
Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice.
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Movement; Disease Models, Animal; Erythromycin; Hydroxyproline; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Lung; Lung Diseases, Interstitial; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; P-Selectin; RNA, Messenger; Vascular Cell Adhesion Molecule-1 | 2002 |
Modulation of neutrophil adhesion to vascular endothelial cells in rat experimental otitis media treated with a macrolide.
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Erythromycin; L-Selectin; Macrophage-1 Antigen; Neutrophils; Otitis Media; Random Allocation; Rats; Rats, Sprague-Dawley | 2003 |
Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model.
Topics: Acetaminophen; Acute Disease; Amoxicillin; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Clavulanic Acid; Disease Models, Animal; Drug Interactions; Erythromycin; Female; Gerbillinae; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Female; Immunocompetence; Ketolides; Mice; Mice, Inbred CBA; Neutropenia; Neutrophils; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2003 |
[Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Depression, Chemical; Disease Models, Animal; Erythromycin; Lung; Mice; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 2003 |
[An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema].
Topics: Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Erythromycin; Hyaluronic Acid; Male; Muscle, Smooth, Vascular; Procollagen; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Radioimmunoassay; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae | 2004 |
Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats.
Topics: Acetic Acid; Animals; Azithromycin; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythromycin; Interferon-gamma; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2005 |
[Action of EM703, a new macrolide derivative, on the lung that has been damaged by influenza virus].
Topics: Animals; Disease Models, Animal; Erythromycin; Influenza A virus; Mice; Orthomyxoviridae Infections; Pneumonia, Viral | 2004 |
Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Erythromycin; Gerbillinae; Microbial Sensitivity Tests; Otitis Media; Pneumococcal Infections; Time Factors; Treatment Outcome | 2005 |
Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
Topics: Animals; Anti-Inflammatory Agents; Carrier Proteins; Disease Models, Animal; Erythromycin; Female; Inflammation; Injections, Intraperitoneal; Interleukin-1; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Osteolysis; Prosthesis Failure; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Skull; Tumor Necrosis Factor-alpha | 2006 |
Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Aurothioglucose; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Dexamethasone; Dietary Fats; Disease Models, Animal; Down-Regulation; Erythromycin; Intestine, Small; Liver; Male; Membrane Proteins; Mice; Mice, Inbred ICR; Microsomes, Liver; Obesity; Rats; Rats, Wistar; RNA, Messenger; Species Specificity; Steroid Hydroxylases; Transcription Factors | 2006 |
Listeria monocytogenes traffics from maternal organs to the placenta and back.
Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Female; Gentamicins; Guinea Pigs; Infectious Disease Transmission, Vertical; Listeria monocytogenes; Listeriosis; Liver; Models, Theoretical; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Animal; Spleen | 2006 |
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Ketolides; Mice; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2006 |
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycin.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Female; Gerbillinae; Humans; Ibuprofen; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
[An experimental study on pulmonary vascular inflammation in a rat model of chronic bronchitis and emphysema].
Topics: Animals; Bronchitis, Chronic; Disease Models, Animal; Erythromycin; Inflammation; Male; Pulmonary Artery; Pulmonary Emphysema; Rats; Rats, Wistar | 2006 |
Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation.
Topics: Animals; Anti-Bacterial Agents; Brain; Brain Ischemia; Disease Models, Animal; DNA, Complementary; Erythromycin; Inflammation; Ischemic Preconditioning; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2007 |
Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools.
Topics: Animals; Constipation; Defecation; Diarrhea; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Erythromycin; Gastrointestinal Agents; Morphine; Motilin; Rabbits; Reference Values | 2007 |
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines | 2007 |
Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Topics: Acetaminophen; Administration, Oral; Animals; Cisapride; Clonidine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Duodenum; Erythromycin; Gastric Emptying; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Postprandial Period; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Stomach; Time Factors; Vagotomy | 2008 |
Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Dogs; Erythromycin; Female; Gastric Emptying; Gastroparesis; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 2008 |
Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne.
Topics: Acne Vulgaris; Animals; Benzoyl Peroxide; Disease Models, Animal; Erythromycin; Female; Fluocinolone Acetonide; Inflammation; Injections, Intradermal; Naproxen; Propionibacterium acnes; Pyrazoles; Rats; Rats, Inbred Strains; Tetracycline; Tretinoin | 1984 |
In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae.
Topics: Animals; Anti-Infective Agents; Cell Death; Cricetinae; Disease Models, Animal; Erythromycin; Fluoroquinolones; Gatifloxacin; Lung; Male; Mesocricetus; Minocycline; Mycoplasma pneumoniae; Piperazines; Pneumonia, Mycoplasma; Quinolones | 1994 |
Laparoscopic-assisted full-thickness endoscopic polypectomy.
Topics: Animals; Cefotetan; Colonic Polyps; Colonoscopes; Colonoscopy; Disease Models, Animal; Electrocoagulation; Erythromycin; Humans; Laparoscopy; Neomycin; Pneumoperitoneum, Artificial; Polyethylene Glycols; Swine; Therapeutic Irrigation | 1993 |
Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred BALB C; Minocycline; Paromomycin; Tetracyclines | 1993 |
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
Topics: Abscess; Animals; Azithromycin; Cephalexin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Male; Mice; Mice, Inbred Strains; Rats; Roxithromycin; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1993 |
A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Female; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Lung | 1993 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Preferential concentration of azithromycin in an infected mouse thigh model.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Erythromycin; Histamine; Inflammation; Male; Mice; Mice, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Thigh | 1993 |
Effect of disturbance of the gastrointestinal microflora on the faecal excretion of Fusobacterium necrophorum biovar A.
Topics: Animals; Bacteria; Digestive System; Disease Models, Animal; Erythromycin; Feces; Female; Fusobacterium Infections; Fusobacterium necrophorum; Kanamycin; Metronidazole; Mice; Phenotype | 1993 |
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Injections, Subcutaneous; Mice; Pneumonia, Pneumococcal; Roxithromycin; Spiramycin | 1995 |
The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Catechols; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gastric Mucosa; Helicobacter Infections; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentanones; Tetracycline; Tinidazole | 1996 |
Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Anemia, Pernicious; Animals; Bacteria, Anaerobic; Citrates; Cystathionine; Disease Models, Animal; Erythromycin; Gastrectomy; Homocysteine; Humans; Intestines; Lincomycin; Male; Methylmalonic Acid; Methylmalonyl-CoA Mutase; Postgastrectomy Syndromes; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Diseases; Vacuoles; Vitamin B 12; Vitamin B 12 Deficiency | 1997 |
Ototoxic effect of erythromycin on cochlear potentials in the guinea pig.
Topics: Animals; Anti-Bacterial Agents; Cochlear Microphonic Potentials; Disease Models, Animal; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Hearing Disorders; Infusions, Intravenous; Instillation, Drug; Perilymph; Time Factors | 1997 |
Prevention of bacterial endocarditis: recommendations by the American Heart Association.
Topics: Algorithms; American Dental Association; American Heart Association; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Clindamycin; Clinical Protocols; Consensus Development Conferences as Topic; Dental Care; Dental Care for Chronically Ill; Disease Models, Animal; Disease Susceptibility; Endocarditis, Bacterial; Erythromycin; Follow-Up Studies; Humans; MEDLINE; Mitral Valve Prolapse; Outcome Assessment, Health Care; Penicillins; Retrospective Studies; Risk Factors; Societies, Medical; Treatment Failure; United States | 1997 |
Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release.
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Erythromycin; Female; Hydroxyproline; Lung; Macrophage Activation; Macrophages, Alveolar; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Rats; Rats, Wistar; Reference Values; Tumor Necrosis Factor-alpha | 1997 |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Disease Models, Animal; Erythromycin; Female; Mice; Peritonitis; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
[Effects of erythromycin on a mouse hypersensitivity pneumonia model].
Topics: Alveolitis, Extrinsic Allergic; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Josamycin; Mice; Mice, Inbred BALB C | 1997 |
Antimicrobial chemotherapy for Legionnaires disease: time for a change.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Disease Models, Animal; Doxycycline; Erythromycin; Humans; Legionnaires' Disease; Tetracycline | 1998 |
Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
Topics: Animals; Bile; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Erythromycin; Gallbladder; Gastrointestinal Motility; Lipid Metabolism; Muscle Contraction; Sciuridae | 1998 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Humans; Methicillin; Microbial Sensitivity Tests; Penicillins; Rabbits; Roxithromycin; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus epidermidis | 1998 |
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifibrinolytic Agents; Blood Coagulation; Carbamazepine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred ICR; Partial Thromboplastin Time; Phenytoin; Piperidines; Prothrombin Time; Rifampin; Sulfonamides; Thromboembolism; Thromboplastin; Vitamin K 1; Warfarin | 1998 |
[Bacterial resistance and new therapeutic perspectives].
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Macrolides; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
Effects of erythromycin on experimental extrinsic allergic alveolitis.
Topics: Alveolitis, Extrinsic Allergic; Animals; Anti-Bacterial Agents; Arthus Reaction; Bronchoalveolar Lavage Fluid; Chemokines, CC; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Erythromycin; Female; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Lung; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Specific Pathogen-Free Organisms; Trichosporon | 1999 |
[Efficacy of erythromycin (EM) on a rabbit model of Pseudomonas aeruginosa-induced chronic bronchiolitis--its action on apoptosis].
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Bronchiolitis; Chronic Disease; Disease Models, Animal; Erythromycin; Male; Pseudomonas Infections; Rabbits | 2000 |
Ketolide ABT-773 is active against Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Erythromycin; Female; Humans; Ketolides; Mice; Toxoplasma; Toxoplasmosis | 2000 |
Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus; Erythromycin; Ketolides; Macrolides; Mice; Microbial Sensitivity Tests; Peritonitis | 2000 |
HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Humans; Ketolides; Macrolides; Male; Penicillins; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae; Treatment Outcome | 2001 |
Therapeutic effects of rifampin and erythromycin in experimental murine brucellosis.
Topics: Animals; Brucella melitensis; Brucellosis; Disease Models, Animal; Erythromycin; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Rifampin; Treatment Outcome | 2000 |
Infection of hamsters with epidemiologically important strains of Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Disease Outbreaks; Enterocolitis, Pseudomembranous; Erythromycin; Mesocricetus; Microbial Sensitivity Tests; Polymerase Chain Reaction; Restriction Mapping; Virulence | 2001 |
Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1.
Topics: Animals; Bronchiolitis; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Erythromycin; Male; Rabbits | 2001 |
[Effects of erythromycin on the Pseudomonas-induced rabbit diffuse panbronchiolitis model--the improvements in granuloma-like lesions with increasing production of MCP-1].
Topics: Animals; Anti-Bacterial Agents; Bronchiolitis; Chemokine CCL2; Disease Models, Animal; Erythromycin; Foam Cells; Granuloma; Lung Diseases; Male; Neutrophil Infiltration; Pseudomonas Infections; Rabbits | 2001 |
[Effects and action mechanisms of macrolides on IgG- immune complex lung injury models].
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Erythromycin; Immune Complex Diseases; Immunoglobulin G; Josamycin; Lung Diseases; Macrophages, Alveolar; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2001 |
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Guinea Pigs; Ketolides; Legionella pneumophila; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Outcome | 2001 |
[mRNA expression of basic fibroblast growth factor in the pulmonary tissues from rats repeatedly infected with mycoplasma pneumoniae].
Topics: Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Lung; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Rats; Rats, Wistar; Recurrence; RNA, Messenger | 1999 |
[The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Cytokines; Disease Models, Animal; Erythromycin; Gene Expression; Interleukin-1; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1999 |
Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.
Topics: Administration, Oral; Animals; Chloramphenicol; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Guinea Pigs; Injections, Subcutaneous; Legionnaires' Disease; Penicillins; Respiratory Tract Infections; Rifampin; Tetracycline | 1978 |
Pneumococcal meningitis-therapeutic studies in mice.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cerebellum; Cerebral Cortex; Chloramphenicol; Chlortetracycline; Demeclocycline; Disease Models, Animal; Erythromycin; Lincomycin; Male; Meningitis, Pneumococcal; Mice; Penicillins; Rolitetracycline; Streptococcus pneumoniae; Tetracycline; Virulence | 1975 |
Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Catheterization; Cefazolin; Cellulitis; Disease Models, Animal; Electrophoresis, Cellulose Acetate; Erythromycin; Inflammation; Injections, Intramuscular; Lymph; Nafcillin; Penicillin G; Proteins; Rabbits | 1979 |
Topical antibiotic therapy of staphylococcal keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Chlortetracycline; Disease Models, Animal; Erythromycin; Gentamicins; Humans; In Vitro Techniques; Keratitis; Neomycin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 1977 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Mice; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Topics: Animals; Bacteremia; Clarithromycin; Disease Models, Animal; Drug Synergism; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 1992 |
Impairment of contractile response to carbachol and muscarinic receptor coupling in gastric antral smooth muscle cells isolated from diabetic streptozotocin-treated rats and db/db mice.
Topics: Animals; Carbachol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Erythromycin; Female; Guanosine 5'-O-(3-Thiotriphosphate); Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Pyloric Antrum; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Streptozocin | 1992 |
Infectious crystalline keratopathy with ring opacity.
Topics: Adult; Animals; Cornea; Corneal Opacity; Corneal Stroma; Crystallization; Disease Models, Animal; Erythromycin; Eye Infections, Bacterial; Humans; Keratitis; Methylprednisolone; Penicillins; Rabbits; Streptococcal Infections; Streptococcus | 1992 |
The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascitic Fluid; Blood Proteins; Dinoprostone; Disease Models, Animal; Erythromycin; Female; Mice; Peritonitis; Time Factors; Treatment Failure; Zymosan | 1992 |
Response of Pasteurella haemolytica to erythromycin and dexamethasone in calves with established infection.
Topics: Albumins; Animals; Cattle; Cattle Diseases; Dexamethasone; Diffusion Chambers, Culture; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Hydrogen-Ion Concentration; Injections, Intramuscular; Leukocyte Count; Mannheimia haemolytica; Neutrophils; Pasteurella Infections; Tissue Distribution | 1992 |
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
Activity of azithromycin against cryptosporidia in immunosuppressed rats.
Topics: Animals; Azithromycin; Cryptosporidiosis; Disease Models, Animal; Erythromycin; Female; Ileum; Immune Tolerance; Random Allocation; Rats; Rats, Inbred Strains; Spiramycin | 1991 |
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Evaluation, Preclinical; Erythromycin; Female; Mice; Roxithromycin; Spiramycin; Tissue Distribution; Toxoplasma; Toxoplasmosis, Animal | 1991 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bacteroides fragilis; Ciprofloxacin; Disease Models, Animal; Erythromycin; Escherichia coli; Female; Liver; Male; Mice; Rats; Salmonella enteritidis; Staphylococcus aureus | 1990 |
In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.
Topics: Animals; Azithromycin; Disease Models, Animal; Erythromycin; Female; Hepatomegaly; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Specific Pathogen-Free Organisms; Splenomegaly | 1989 |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Disease Models, Animal; Erythromycin; Female; Gerbillinae; Half-Life; Haplorhini; Male; Rats; Species Specificity; Tissue Distribution | 1987 |
Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model.
Topics: Acute Disease; Ampicillin; Animals; Azithromycin; Chinchilla; Disease Models, Animal; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Otitis Media | 1988 |
The effect of tetracycline and erythromycin in a model of acne-type inflammation.
Topics: Acne Vulgaris; Animals; Disease Models, Animal; Erythromycin; Guinea Pigs; Inflammation; Oxytetracycline; Skin | 1987 |
Comparison of spiramycin and erythromycin in the treatment of experimental guinea pig legionellosis.
Topics: Animals; Disease Models, Animal; Erythromycin; Guinea Pigs; Legionella; Legionnaires' Disease; Leucomycins; Male | 1988 |
Experimental infection of the hamster with Borrelia burgdorferi.
Topics: Animals; Borrelia; Borrelia Infections; Cricetinae; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Host-Parasite Interactions; Immunity; Immunization, Passive; Penicillin Resistance; Species Specificity | 1988 |
[Animal experiments with Campylobacter coli using suckling pigs].
Topics: Animals; Animals, Suckling; Campylobacter Infections; Disease Models, Animal; Erythromycin; Neomycin; Swine; Swine Diseases | 1988 |
[Treatment with erythromycin of experimental legionellosis in guinea pigs infected by aerosol].
Topics: Animals; Disease Models, Animal; Erythromycin; Guinea Pigs; Legionnaires' Disease; Male | 1986 |
Urease-inhibiting action of some drugs in vitro and in vivo.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycline; Demeclocycline; Depression, Chemical; Disease Models, Animal; Enzyme Repression; Erythromycin; Female; Hydroxamic Acids; In Vitro Techniques; Intestines; Kanamycin; Male; Neomycin; Niacinamide; Oxytetracycline; Penicillin G; Rats; Streptomycin; Sulfamethoxypyridazine; Sulfisoxazole; Sulfonamides; Tetracycline; Urease | 1970 |
[Antibacterial action of erythromycin on experimental E. coli cystitis during alkalinization of the urine in rats].
Topics: Ammonium Chloride; Animals; Bacteriuria; Bicarbonates; Cystitis; Disease Models, Animal; Erythromycin; Escherichia coli Infections; Female; Hydrogen-Ion Concentration; Rats | 1970 |
[Antibacterial action of erythromycin on experimental E. coli cystitis during alkalinization of the urine in rats].
Topics: Ammonium Chloride; Animals; Bacteriuria; Bicarbonates; Cystitis; Disease Models, Animal; Erythromycin; Escherichia coli Infections; Female; Hydrogen-Ion Concentration; Rats | 1970 |
[Transmission of extrachromosomal drug resistance in staphylococci present in animals and the effect of neomycin on this process].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Extrachromosomal Inheritance; Genetics, Microbial; Kidney; Lysogeny; Methods; Mice; Neomycin; Staphylococcal Infections; Staphylococcus | 1970 |
The writhing test with erythromycin.
Topics: Analgesics; Animals; Disease Models, Animal; Erythromycin; Male; Mice; Quinones; Spasm | 1970 |
Study of bactericidal and bacteriostatic antibiotics in experimentally diabetic and senescent mice, in cases of lethal staphylococcal infection.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Erythromycin; Immunosuppression Therapy; Male; Mice; Neomycin; Oxacillin; Staphylococcal Infections | 1971 |